These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33472986)

  • 1. Conservative Management of Alloimmune Hemolysis and Cholestasis With Extreme Laboratory Abnormalities.
    Kotch C; Friedman DF; Wilkins BJ; Samelson-Jones BJ
    Pediatrics; 2021 Feb; 147(2):. PubMed ID: 33472986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome.
    Smits-Wintjens VE; Rath ME; Lindenburg IT; Oepkes D; van Zwet EW; Walther FJ; Lopriore E
    Neonatology; 2012; 101(4):306-10. PubMed ID: 22354012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative Management of Hyperferritinemia in Hemolytic Disease of the Fetus and Newborn: A Case Report and Review of the Literature.
    Adam DL; Bowes L; Goodyear L; Moorehead PC
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):73-76. PubMed ID: 31460887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Fetal Hemolysis and Cholestasis Due to High-Titer Maternal IgG Anti-A Antibodies.
    Zonneveld R; van der Meer-Kapelle L; Sylva M; Brand A; Zijlstra M; Schonewille H
    Pediatrics; 2019 Apr; 143(4):. PubMed ID: 30872329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History and current standard of postnatal management in hemolytic disease of the fetus and newborn.
    De Winter DP; Hulzebos C; Van 't Oever RM; De Haas M; Verweij EJ; Lopriore E
    Eur J Pediatr; 2023 Feb; 182(2):489-500. PubMed ID: 36469119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based incidence and risk factors for cholestasis in hemolytic disease of the fetus and newborn.
    Teng J; Wickman L; Reilly M; Nemeth A; Fischler B; Bohlin K; Tiblad E
    J Perinatol; 2022 Jun; 42(6):702-707. PubMed ID: 35194159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron status in infants with alloimmune haemolytic disease in the first three months of life.
    Rath ME; Smits-Wintjens VE; Oepkes D; Walther FJ; Lopriore E
    Vox Sang; 2013 Nov; 105(4):328-33. PubMed ID: 23802744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
    Kulinska R
    Akush Ginekol (Sofiia); 2014; 53(2):58-63. PubMed ID: 25098112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemic Disease of the Newborn With Little Increase in Hemolysis and Erythropoiesis Due to Maternal Anti-Jr
    Katsuragi S; Ohto H; Yoshida A; Otake A; Tsuneyama H; Ogasawara K; Isa K; Ikeda T
    Transfus Med Rev; 2019 Jul; 33(3):183-188. PubMed ID: 31227265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
    Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chelation therapy for secondary neonatal iron over load: Lessons learned from rhesus hemolytic disease.
    Khdair-Ahmad F; Aladily T; Khdair-Ahmad O; Badran EF
    Turk J Pediatr; 2018; 60(3):335-339. PubMed ID: 30511551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe case of fetal hemolytic disease caused by anti-C(w) requiring serial intrauterine transfusions complicated by pancytopenia and cholestasis.
    Macher S; Wagner T; Rosskopf K; Reiterer F; Csapo B; Schlenke P; Klaritsch P
    Transfusion; 2016 Jan; 56(1):80-3. PubMed ID: 26496681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic disease of the fetus and newborn owing to anti-U, successfully treated with repeated intrauterine transfusions.
    Strindberg J; Lundahl J; Ajne G
    Immunohematology; 2013; 29(2):51-4. PubMed ID: 24094236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.
    de Winter DP; Kaminski A; Tjoa ML; Oepkes D
    BMC Pregnancy Childbirth; 2023 Jan; 23(1):12. PubMed ID: 36611144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review.
    Blyth U; Larsson M; Baird A; Waring G; Athiraman N
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10220-10225. PubMed ID: 36121063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemolytic disease of the fetus and newborn.
    de Haas M; Thurik FF; Koelewijn JM; van der Schoot CE
    Vox Sang; 2015 Aug; 109(2):99-113. PubMed ID: 25899660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
    Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
    Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic disease of the fetus and newborn mediated by anti-Di
    Jacobs JW; Abels E; Binns TC; Tormey CA; Sostin N
    Immunohematology; 2023 Apr; 39(1):32-34. PubMed ID: 37017601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
    Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
    Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion medicine and the pregnant patient.
    Lee AI; Kaufman RM
    Hematol Oncol Clin North Am; 2011 Apr; 25(2):393-413, ix. PubMed ID: 21444037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.